Mahwah: Glenmark Pharmaceuticals Inc., USA has announced the launch of Epinephrine Injection USP, 10 mg/10 mL (1 mg/mL) ...
Glenmark launches generic Epinephrine injection in the US, eligible for 180 days of competitive generic therapy exclusivity.
Glenmark Pharma launches epinephrine injection USP, 10 mg/10 mL (1 mg/mL) multiple-dose vial: Our Bureau, Mumbai Thursday, February 27, 2025, 12:30 Hrs [IST] Glenmark Pharmaceutic ...
FDA drug alerts in endocrinology, including drug approvals, drug warnings, FDA medical device recalls, and FDA drug label ...
Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the launch1 of Epinephrine Injection USP, 10 mg/10 mL (1 mg/mL) ...
Glenmark Pharmaceuticals launches generic Epinephrine injection in the US, eligible for 180 days of CGT exclusivity. The ...
(RTTNews) - Glenmark Pharmaceuticals Limited US, Thursday announced the launch of Epinephrine Injection USP, 10 mg/10 mL Multiple-Dose Vial. The company added that the newly launched product is ...
1 Glenmark's Epinephrine Injection USP, 10 mg/10 mL (1 mg/mL) Multiple-Dose Vial is only approved for the indication(s) listed in Glenmark's approved label. 2 Market includes brand and all ...
Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the launch of Epinephrine Injection USP, 10 mg/10 mL (1 mg/mL) Multiple-Dose Vial. Glenmark's Epinephrine Injection USP, 10 mg/10 mL (1 mg/mL) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback